Diebold Nixdorf, Incorporated
DBD · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $3 | $3 | $2 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 3.3% | 8.8% | -14.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.2% | 25.6% | 24.1% | 23.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 11.1% | 7.7% | 5.7% | 13.4% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 4.3% | 1.3% | -1% | 0.6% |
| EPS Diluted | 1.09 | 0.33 | -0.22 | 0.15 |
| % Growth | 230.3% | 250% | -246.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |